PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
October 18, 2025Journal of Clinical MedicineOpen Access

Antithrombotic Therapy in the Elderly with Cardiovascular Disease: Walking the Tightrope Between Efficacy and Bleeding Risk—A Narrative Review

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAlessandro SciahbasiSMSimona MinardiNSNicolò Salvi

Discussion

Loading...

Member takes

Overview

Narrative review discusses antithrombotic therapy efficacy in elderly patients, highlighting the challenge of bleeding risk.

Key Points

  • Balancing efficacy and bleeding risk is crucial for elderly patients receiving antithrombotic therapy, especially with cardiovascular disease.
  • Elderly patients are underrepresented in randomized trials, leading to limited age-specific guidelines for antithrombotic management.
  • Therapeutic strategies for elderly patients must consider individual clinical conditions, as risks and benefits vary significantly.
  • New treatment options and strategies for antithrombotic therapy in the elderly are emerging, potentially improving patient outcomes.

Cite This Study

Sciahbasi et al. (2025) studied this question.

synapsesocial.com/papers/68f35bfc73f0a7d050f47d3chttps://doi.org/10.3390/jcm14207340
View Full Paper
Ask AI
Bookmark
Share